UnitedHealth Group Incorporated (UNH) 2024 10-K Earnings Analysis
UnitedHealth Group Incorporated2024 Earnings Analysis
74/100
UnitedHealth's FY2024 10-K shows a $400B revenue integrated healthcare giant absorbing two shocks: the Change Healthcare cyberattack (February 2024, billions in remediation + claims processing disruption) and margin pressure across UnitedHealthcare from Medicare Advantage utilization running hotter than priced. Net income of $14.4B on $400.3B revenue yields just 3.6% net margin — typical for the insurer side — while OCF of $24.2B and FCF of $20.7B show the business still generates serious cash. The strategic bet is Optum: the 10-K describes it as 'a higher-performing, value-oriented and more connected approach to health care' spanning health services, analytics, and pharmacy — a vertical integration thesis that makes UNH unique vs pure-play insurers.
Filing analysis
UnitedHealth Group Incorporated 2024 10-K Analysis
This page reads UnitedHealth Group Incorporated's 2024 10-K annual report through the EarningsMoat framework: earnings quality, economic moat strength, capital allocation, and key risks. The current overall score is 74/100, or grade C.
UNH Earnings Quality
The earnings-quality module scores 76/100, with Net Margin: 3.6%, CF/Net Income: 1.68x. The core question is whether reported profit is backed by operating cash flow and recurring business economics. See the earnings quality analysis guide.
UNH Economic Moat Analysis
The moat-strength module scores 83/100, with Vertical Integration: Unique at scale, Network Scale: Dominant. The test is whether the advantage can protect returns after competitors react. Read the economic moat analysis guide.
UNH Free Cash Flow vs Net Income
CF/Net Income: 1.68x is the fastest read on whether accounting earnings turn into cash. The capital-allocation module scores 76/100. For the diagnostic, start with cash flow vs net income.
UNH Key Risks from the Annual Report
The risk module scores 60/100, with Medicare Advantage Utilization: Acute, Regulatory / DOJ Scrutiny: Elevated. The goal is to separate ordinary disclosure from risks that can change margins, cash flow, leverage, or the moat itself.
Is UNH a High Quality Earnings Stock?
Based on this 2024 filing, UNH needs a closer read before it qualifies as a high-quality earnings candidate: the overall grade is C, and the earnings-quality score is 76/100. This is a research screen, not investment advice.
Read the report first
Understand UnitedHealth Group Incorporated first, then decide if it belongs on your watchlist
The UNH score, explanation, management facts, and filing sources are all here. When you want to follow more companies, review new-filing changes, or keep notes for the next review, keep more names in your watchlist.
Read the report first
Understand the company first. Keep up with every filing as your list grows.
A single report helps you judge one company. As your watchlist grows, review score, cash flow, moat, and risk changes together instead of repeating the same work.
Keep more names together
When your list grows, keep UNH with the rest of your names and review score, grade, and risk changes over time.
See how to track more namesAsk follow-up questions
Dig into cash conversion, moat evidence, capital allocation, and risk changes without rereading the full 10-K.
Ask a questionExport and revisit records
Save the UNH report as research notes you can revisit before the next filing.
Save research notesCore Dimension Scores
Evaluating competitive strength across earnings quality, moat strength, and risk sustainability
Overall Score Trend
Earnings Quality
Net income of $14.4B on $400.3B revenue = 3.6% net margin — structurally low for an insurance-heavy business. FY2024 was hit by elevated Medicare Advantage medical-loss ratios + the Change Healthcare incident; normalized margin sits closer to 5-6%. Optum contributes higher-margin service revenue, gradually lifting the blended profile.
OCF of $24.2B against NI of $14.4B = 1.68x conversion — robust. The gap reflects large non-cash D&A on Optum's care-delivery assets plus insurance-reserve accounting timing. Cash-based earnings power exceeds GAAP NI.
Per the FY2024 10-K, revenue was $400.3B — a scale that places UnitedHealth at the top of the global healthcare-company revenue rankings per Fortune Global 500 published listings. The 10-K describes Optum and UnitedHealthcare as the two segments; Optum itself has three sub-segments (Health, Insight, Rx). Scale gives negotiating leverage on provider contracts and drug pricing.
February 2024's ransomware attack on Change Healthcare (a UnitedHealth subsidiary) disrupted claims processing for weeks. UNH reported multi-billion remediation costs and business-interruption losses across FY2024. The incident exposed how concentrated US healthcare claims infrastructure had become post-Optum-Change merger.
Earnings quality scores 76/100. The 3.6% net margin is structurally constrained by the insurance model — UNH collects premiums and pays out most in medical claims. 1.68x CF/NI is the real story: non-cash charges suppress GAAP NI, so cash generation is significantly stronger. FY2024 was a rough year (Change Healthcare cyber + MA utilization spike) and the numbers reflect that; normalized earnings power is higher than this snapshot shows.
Moat Strength
The 10-K describes Optum as spanning 'Optum Health, Optum Insight and Optum Rx' — a provider network, data/analytics platform, and PBM respectively. Combined with UnitedHealthcare insurance, UNH captures the full healthcare dollar flow. No competitor (CVS/Aetna, Cigna/Evernorth) has matched the integration depth.
UNH serves 50M+ insurance members; Optum Health serves 100M+ patient lives through its care delivery footprint. The 10-K describes Optum's reach including 'patients and consumers, payers, care providers, employers, governments and life sciences companies' — breadth that creates data + negotiating advantages smaller competitors can't match.
Optum Insight leverages 'distinctive capabilities in data and analytics' (per 10-K) built on decades of claims data from UnitedHealthcare. This data asset is difficult to replicate — competitors would need years of claims volume to build comparable datasets.
Per CMS Medicare Advantage enrollment reports, UnitedHealthcare is among the largest Medicare Advantage insurers by enrollment, a position also referenced in the FY2024 10-K insurance segment disclosures. MA enrollment grew FY2024 but margins compressed as utilization exceeded pricing assumptions. The long-term demographic tailwind (aging population) is intact; the short-term risk is continued MLR pressure into FY2025.
Moat strength scores 83/100. The vertical integration thesis is UNH's unique advantage — owning insurance + care delivery + analytics + PBM creates data and cost-management edges that pure insurers can't match. The 10-K's positioning of Optum to 'advance whole-person health' while serving 'patients and consumers, payers, care providers, employers, governments and life sciences companies' captures the breadth. Short-term MA headwinds don't break the moat; regulatory scrutiny of MA upcoding is a longer-dated concern.
Capital Allocation
FCF of $20.7B = 5.2% FCF margin on $400B revenue. Low margin is structural for insurance/healthcare; absolute cash generation is enormous and supports $7B+ annual dividend + buyback program.
ROE of 14.7% (NI $14.4B / Equity $98.3B) — solid quality return for a healthcare insurer. Not engineered via extreme leverage (debt ratio 67% moderate) and the large equity base reflects decades of retained earnings plus the 2015 Catamaran + 2022 Change Healthcare deals.
Goodwill of $98B = 35.8% of $275B assets — very high, reflecting UNH's acquisition-heavy growth: Catamaran ($12.8B, 2015), Change Healthcare ($13B, 2022), Amedisys (pending), Surgical Care Affiliates, DaVita Medical Group, and dozens of physician practices. Goodwill impairment risk rises if Optum integration underdelivers.
UNH has raised its dividend for 15+ consecutive years with consistent double-digit growth rates. Combined with buybacks, total capital return regularly exceeds $10B/year, covered multiple times by FCF.
Capital allocation scores 76/100. FCF scale is impressive in absolute terms ($20.7B), and the dividend track record is clean. The 35.8% goodwill ratio is the caveat — UNH has built Optum through serial M&A, and if any major franchise (Change Healthcare, Amedisys-if-closes, the physician practices) underperforms, impairment pressure materializes. The 67% debt ratio is moderate — room for continued bolt-on M&A without straining the balance sheet.
Key Risks
MA utilization ran above pricing assumptions through FY2024, compressing margins. FY2025 pricing attempts to re-balance but CMS reimbursement rates are also under pressure. This is the single biggest near-term earnings risk — UNH's largest growth engine facing margin compression.
Per DOJ's 2024 public complaint and subsequent abandonment disclosures, the DOJ antitrust case blocked the Amedisys home-health acquisition. Ongoing False Claims Act investigations into MA coding practices. Change Healthcare cyber incident drew HHS/OCR HIPAA enforcement attention. Per the FY2024 10-K Risk Factors and the DOJ/CMS/state-attorneys-general public filings cited in successive periodic reports, cumulative regulatory attention on UnitedHealth is elevated relative to prior periods.
The February 2024 Change Healthcare ransomware attack demonstrated that UNH's infrastructure concentration is a systemic risk. Remediation + claims-processing disruption costs ran into billions. Cyber risk is no longer theoretical for UNH specifically.
At 35.8% of assets, goodwill creates impairment exposure if Optum's value-creation thesis falters. Any single acquired franchise underdelivering against its purchase-accounting model triggers a write-down. Cumulative risk from decades of M&A has built up on the balance sheet.
Risk profile scores 60/100 (higher = safer) — the lowest among this batch's peer set because UNH faces acute and rising pressure on multiple fronts. MA utilization is the defining short-term earnings risk. Per DOJ public filings blocking the Amedisys transaction and the DOJ's publicly-reported MA-coding investigations, regulatory scrutiny on UnitedHealth is material and ongoing. Cyber exposure is now proven by the Change Healthcare incident. And 35.8% goodwill means M&A integration underperformance could trigger multi-billion writedowns. Despite these, the underlying scale + integration moat is real and the business generates massive cash.
Management
Ask about this section
Ask one question here. Keep digging when the issue needs more work.
This analysis is for educational purposes only and does not constitute investment advice.